Almonty's First Tungsten Cargo Is Booked. Its Legal Bill Is Not.
Published on 11/18/2026 at 11:31 | Editorial boerse-global.deAlmonty has cleared one hurdle and walked straight into another. The first container of tungsten concentrate from its Sangdong operation was loaded in Busan for overseas shipment after the quarter closed — a genuine operational step, though not yet proof of a mine that can deliver on a schedule. At the same time, a Canadian legal fight with Deutsche Rohstoff is widening, and the company's headline profit owes almost everything to accounting marks rather than metal.
What the quarter actually earned
Revenue for the third quarter of 2026 came in at C$41.9 million, up 382% year on year. Adjusted EBITDA reached C$14.6 million. The net profit of C$50.2 million was larger than revenue itself — a figure that demands unpacking before anyone treats it as earning power.
Roughly C$47.9 million of that bottom line consisted of non-cash net gains from revaluing derivative and warrant instruments. Those marks explain the bulk of the reported surplus and say nothing about whether Sangdong can sell tungsten at a profit quarter after quarter. Adjusted EBITDA is the more useful yardstick, though it too should not be mistaken for cash in the bank. As of September 30, 2026, Almonty held C$1.15 billion in cash.
The dispute, sized and scheduled
Deutsche Rohstoff puts its claims against Almonty in Canada at approximately US$67 million, centered mainly on conversion rights and outstanding loans. Almonty has filed a counterclaim, and according to Deutsche Rohstoff the two proceedings have been consolidated. Consolidation settles nothing about the merits; it is a procedural step, not a verdict. Nor does the counterclaim offer any relief yet.
The distinction investors need to hold onto is between a claim and a loss. The US$67 million describes what Deutsche Rohstoff is seeking, not what a court will award. A large cash position does not substitute for that analysis, and neither does a counterclaim erase the original exposure.
Should investors sell immediately? Or is it worth buying Almonty?
Two analysts, one message
B. Riley cut its price target to $18 yesterday while keeping its buy rating. Stifel trimmed its own target to $18 on Friday, also maintaining a buy. The pattern is consistent: both houses lowered their marks without abandoning their positive stance. Reading the ratings while ignoring the cuts would miss half the story.
Board changes and a Korean ambition
David Hanick and Andrew Frazer are set to leave the supervisory board on December 31, 2026. Eugene Bae and Jim Rudyk were appointed as independent members yesterday with immediate effect. Separately, Almonty is pursuing a secondary listing on the Korea Exchange — an intention, not an accomplishment, and no stand-in for evidence that Sangdong can ship repeatedly.
What would settle the argument
Sangdong produced tungsten concentrate for the first time in September 2026. Loading a single container marks a different milestone from producing the concentrate in the first place; together they show progress from output to export, but they do not yet amount to a delivery record spanning multiple reporting periods.
The bullish case rests on turning that first cargo into a rhythm. Confirmed repeat shipments would gradually shift the investment case from a successful start-up to a repeatable operation, and each confirmation would chip away at the doubt over whether Sangdong can contribute durably. The C$1.15 billion cash cushion provides additional ballast along the way. Should the financial fallout from the Canadian case stay contained, the operating story could regain the upper hand in how the stock is valued.
The bear case has two separate legs. One is that the reported net profit sets expectations the underlying business cannot carry — non-cash revaluation gains do not by themselves demonstrate operating strength, and a large surplus does not translate into an equally large sustainable earnings base. The other is that an adverse ruling in Canada could weigh on the valuation. The worst combination would be weaker operations arriving alongside bad legal news, pressuring both the earnings outlook and the assessment of potential liabilities.
For now, the positive scenario holds as long as Almonty confirms its operating trajectory and no unfavorable ruling lands. A disappointing earnings trend or a concrete legal hit would force the valuation to be rebuilt around those risks. The December 31 board departure is a fixed date on the calendar, but it answers neither the earnings question nor the legal one. The catalysts that matter are further operating results and substantive developments in the Canadian proceedings — tracked separately, because only the interplay between durable earning power and the actual legal outcome will decide how convincing Almonty's profit picture looks from here.
Ad
Almonty Stock: New Analysis - 18 November
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
